Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
GoodRx Holdings, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-44.9% vs price
Base Case (Median)
18.7% vs price
Bull Case (75th pct.)
29.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $4.44 | 26.1% | High (40%) |
| PE Comparable | $1.04 | -70.3% | Medium (25%) |
| Growth Trajectory DCF | $3.92 | 11.4% | Medium (20%) |
| Graham Number | $1.28 | -63.7% | Low (10%) |
| EV/EBITDA | $4.61 | 30.8% | Medium (20%) |
| EV/FCF | $10.79 | 206.5% | Medium (20%) |
Based on 6 out of 7 methods, GDRX appears fairly valued at the current price of $3.52. The base case fair value of $4.18 implies 18.7% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.